CANAKINUMAB TREATMENT IN PATIENTS WITH COLCHICINE-RESISTANT FMF (CRFMF), HIDS/MKD AND TRAPS: EFFICACY IN THE 16 WEEKS RANDOMISED CONTROLLED PHASE AND MAINTENANCE OF DISEASE CONTROL AND SAFETY AT WEEK 40
Yazar
Ozen, S.
De Benedetti, F.
Gattorno, M.
Frenkel, J.
Calvo, I.
Moutschen, M.
Quartier, P.
Anton, J.
Kone-Paut, I.
Lachmann, H.
Hoffman, H. M.
Ben-Chetrit, E.
Zeft, A.
Gong, Y.
Vritzali, E.
Junge, G.
Gul, A.
Kasapcopur, O.
Üst veri
Tüm öğe kaydını gösterBağlantı
http://hdl.handle.net/20.500.12627/38902https://doi.org/10.1136/annrheumdis-2017-eular.2194
Koleksiyonlar
- Bildiri [64839]